90192-47-5Relevant articles and documents
Synthetic method of (S)-N'-(2-benzyloxy propylidene)formhydrazide
-
Paragraph 0034-0035; 0041-0042; 0046-0047, (2019/05/08)
Disclosed is a synthetic method of (S)-N'-(2-benzyloxy propylidene)formhydrazide. The method includes the following steps: firstly, (S)-2-benzyloxy propionic acid with an acylation reagent to obtain (S)-2-benzyloxy propionyl chloride; and adding a palladi
Method for synthesizing N'-[(2S, 3S)-2-(benzyloxy) pentyl-3-base] formylhydrazine
-
Paragraph 0039; 0040; 0048; 0049; 0055; 0056, (2019/06/27)
A method for synthesizing N'-[(2S, 3S)-2-(benzyloxy) pentyl-3-base] formylhydrazine comprises the following steps: reacting (S)-2-benzyloxypropionic acid with an acylation reagent to obtain (S)-2-benzyloxy propionyl chloride; adding a palladium barium sulfate catalyst into o-xylene and reacting in hydrogen atmosphere for 15-30 min; adding (S)-2-benzyloxy propionyl chloride hydrogen atmosphere forreflux reaction until hydrogen is not absorbed; after the reaction is finished, the catalyst is filtered and the o-xylene is removed to obtain (S)-2-benzyloxypropionaldehyde; reacting the (S)-2-benzyloxypropionaldehyde with formylhydrazine, removing the solvent after finishing the reaction, and post-treating to obtain (S)-N'-(2 benzyloxypropyl) formylhydrazine; reacting the (S)-N'-(2 benzyloxypropyl) formylhydrazine with a Grignard reagent, and post-treating to obtain N'-((2s,3s)- 2-(benzyloxy) pentyl-3-base] formylhydrazine. According to the invention, an acylating reagent which is low in price and safer and more environment-friendly in reaction and a palladium barium sulfate catalyst which can be recycled for a plurality of times are used as reaction raw materials, so that the reaction process more conforms to the principle of atom economy, and the reaction is milder.
Useful for treating neurodegenerative diseases
-
, (2008/06/13)
Novel benzomorphan derivatives of the formula STR1 wherein R1 -R8 are as defined herein. The benzomorphan derivatives are useful for treating cerebral ischaemia of various origins, epilepsy and neurodegenerative diseases.